These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8627886)

  • 1. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit.
    Azadzoi KM; Siroky MB; Goldstein I
    J Urol; 1996 May; 155(5):1795-800. PubMed ID: 8627886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model.
    Azadzoi KM; Park K; Andry C; Goldstein I; Siroky MB
    J Urol; 1997 Mar; 157(3):1011-7. PubMed ID: 9072535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study.
    Henry GD; Byrne R; Hunyh TT; Abraham V; Annex BH; Hagen PO; Donatucci CF
    Int J Impot Res; 2000 Dec; 12(6):334-9. PubMed ID: 11416837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle.
    Azadzoi KM; Krane RJ; Saenz de Tejada I; Goldstein I; Siroky MB
    J Urol; 1999 Apr; 161(4):1324-8. PubMed ID: 10081902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit.
    Azadzoi KM; Tarcan T; Siroky MB; Krane RJ
    J Urol; 1999 May; 161(5):1626-35. PubMed ID: 10210430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence based assessment of erectile dysfunction.
    Broderick GA
    Int J Impot Res; 1998 May; 10 Suppl 2():S64-73; discussion S77-9. PubMed ID: 9647964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing erectile dysfunction: instruments for the study of smooth muscle relaxation.
    Pescatori ES; Morgia G; Pirozzi-Farina F
    Int J Androl; 2005 Dec; 28 Suppl 2():56-60. PubMed ID: 16236066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of corporal veno-occlusive dysfunction.
    Lewis RW
    Semin Urol; 1990 May; 8(2):113-23. PubMed ID: 2191399
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats.
    Kovanecz I; Rambhatla A; Ferrini M; Vernet D; Sanchez S; Rajfer J; Gonzalez-Cadavid N
    Int J Impot Res; 2008; 20(2):202-12. PubMed ID: 17882231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of erectile function by suppression of corporal apoptosis, fibrosis and corporal veno-occlusive dysfunction with rho-kinase inhibitors in a rat model of cavernous nerve injury.
    Cho MC; Park K; Kim SW; Paick JS
    J Urol; 2015 May; 193(5):1716-23. PubMed ID: 25444982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction.
    Kang KK; Yu JY; Yoo M; Kwon JW
    Int J Impot Res; 2005; 17(5):409-16. PubMed ID: 15920460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction.
    Hewawasam P; Fan W; Ding M; Flint K; Cook D; Goggins GD; Myers RA; Gribkoff VK; Boissard CG; Dworetzky SI; Starrett JE; Lodge NJ
    J Med Chem; 2003 Jul; 46(14):2819-22. PubMed ID: 12825925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-dimensional theoretical model of the relationship between cavernosal expandability and percent cavernosal smooth muscle.
    Luo H; Goldstein I; Udelson D
    J Sex Med; 2007 May; 4(3):644-655. PubMed ID: 17498102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction.
    Nehra A; Azadzoi KM; Moreland RB; Pabby A; Siroky MB; Krane RJ; Goldstein I; Udelson D
    J Urol; 1998 Jun; 159(6):2229-36. PubMed ID: 9598575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Erectile Dysfunction.
    Melman A; Rehman J
    Mol Urol; 1999; 3(2):87-102. PubMed ID: 10851310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of castration and testosterone replacement on veno-occlusion during penile erection in the rat.
    Dai YT; Stopper V; Lewis R; Mills T
    Asian J Androl; 1999 Jun; 1(1-2):53-9. PubMed ID: 11225905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of the animal model of induced high-cholesterol-atherosclerotic erectile dysfunction and the mechanisms of atherosclerotic erectile dysfunction].
    Yang G; Chen Z; Wang H
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):608-11. PubMed ID: 15362526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection.
    Christ GJ
    Urol Clin North Am; 1995 Nov; 22(4):727-45. PubMed ID: 7483125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.